Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Evaluation of AdvanCore Bone Graft for Bone Healing

Official title: Study on Safety and Performance of AdvanCore Bone Void Filler

Run by Artur Salgado SA · NCT06736457 · Data updated 2026-11-12

This study is testing if the AdvanCore bone graft can help adults with serious bone defects heal better over a year.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment190 (estimated)
SponsorArtur Salgado SA
Industry-sponsored
Locations4 sites (Guimarães, Braga District and 3 other locations)
StatusRecruiting
StartedMay 29, 2025
Main results expectedOctober 2026
Study endsOctober 2026
Registry record updatedMay 31, 2025
Trial IDNCT06736457 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who require a bone grafting procedure for non-healing bone lesions.

Probably not a fit

Patients with infections at the graft site or those who are hypersensitive to any components of AdvanCore may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and performance of the AdvanCore bone graft, a porous beta-tricalcium phosphate device, over a 12-month follow-up period. It is designed for adult patients with bone defects that exceed the body's natural healing capabilities, and it will be conducted in a multi-center, open-label format across various European sites. Participants will receive the AdvanCore graft, which acts as a temporary scaffold to aid in bone regeneration, and will be monitored for outcomes related to safety and effectiveness.

Why it matters

Potential benefit: If successful, this study could improve bone healing outcomes for patients with significant bone defects.

How similar studies have gone: Other studies involving beta-tricalcium phosphate bone grafts have shown promising results, indicating that this approach is supported by prior research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult subjects ≥ 18 years old, male or female.
* Subjects who are eligible for a bone grafting/bone void filler procedure.
* Subjects with bone lesions beyond the limits of the bone's self-healing ability.
* Subjects, and/or an authorized representative, who are willing and capable of providing informed consent, participating in all testing associated with this clinical investigation at an approved clinical investigational center.
* Subjects with only one fracture susceptible to treatment with an AdvanCore implant.

Exclusion Criteria:

* Subjects with any AdvanCore contraindication for implantation or use.
* Subjects with hypersensitivity to any of the AdvanCore components.
* Subjects with infections or soft/granulation tissue in the area to place bone graft.
* Subjects who are currently enrolled in another investigational study or registry that would directly interfere with the current study.
* Women who are breastfeeding or of childbearing potential who are, or plan to become, pregnant during the time of the study (method of assessment upon physician's discretion).

Where it's running

  • Unidade Local de Saúde do Alto Ave
    Guimarães, Braga District, Portugal
    Recruiting
  • Unidade Local de Saúde de Trás-os-Montes e Alto Douro
    Lordelo, Vila Real District, Portugal
    Recruiting
  • Unidade Local de Saúde de São João
    Porto, Porto District, Portugal
    Not yet recruiting
  • Unidade Local de Saúde do Médio Tejo
    Tomar, Santarém District, Portugal
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.